About this trial
Further studies are needed to investigate the prognosis and perioperative safety of patients undergoing robotic-assisted pancreaticoduodenectomy. In this study, clinical data and prognostic data of patients undergoing this procedure were prospectively collected and analyzed to explore its safety and efficacy.
Eligibility criteria
Qualifiers
Over 18 years old
Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy
No distant transfer
No significant vascular invasion was received
Disqualifiers
With tumors of other organs
Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs
Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery
Preoperative adjuvant therapy was given
Trial design
Treatments tested in this trial
- Robot-assisted Pancreaticoduodenectomy